National Health Investors (NYSE:NHI – Get Free Report) updated its FY 2024 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 4.370-4.430 for the period, compared to the consensus estimate of 4.350. The company issued revenue guidance of -.
Analyst Ratings Changes
A number of equities research analysts have commented on the company. Deutsche Bank Aktiengesellschaft assumed coverage on National Health Investors in a research report on Tuesday, January 30th. They issued a buy rating and a $69.00 target price on the stock. BMO Capital Markets raised shares of National Health Investors from a market perform rating to an outperform rating and set a $67.00 price target for the company in a research report on Tuesday, March 12th. Truist Financial boosted their price objective on National Health Investors from $55.00 to $58.00 and gave the stock a hold rating in a research report on Thursday, April 4th. Wells Fargo & Company raised shares of National Health Investors from an equal weight rating to an overweight rating and lifted their price objective for the stock from $55.00 to $63.00 in a research report on Monday, February 26th. Finally, StockNews.com lowered National Health Investors from a buy rating to a hold rating in a research report on Thursday, April 18th. Five equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of Hold and a consensus target price of $60.50.
Read Our Latest Research Report on NHI
National Health Investors Stock Down 0.0 %
National Health Investors Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 2nd. Shareholders of record on Friday, June 28th will be paid a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 5.48%. The ex-dividend date is Friday, June 28th. National Health Investors’s dividend payout ratio is currently 115.02%.
Insider Transactions at National Health Investors
In other National Health Investors news, Director Charlotte A. Swafford acquired 10,000 shares of the company’s stock in a transaction on Tuesday, February 27th. The shares were bought at an average cost of $58.69 per share, for a total transaction of $586,900.00. Following the completion of the purchase, the director now owns 110,185 shares in the company, valued at approximately $6,466,757.65. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 8.21% of the company’s stock.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Stories
- Five stocks we like better than National Health Investors
- The Significance of Brokerage Rankings in Stock Selection
- No New Highs for Cloudflare in 2024
- Conference Calls and Individual Investors
- Electronic Arts Earnings Engaging Players and Building Value
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 3 Tripe-Digit Growth Mid Cap Stocks to Watch This Quarter
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.